knowledge -WSS

knowledge

author：entertainment 2025-09-28 00:47:51 - browse：919

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

hotspot

WSS

Paxlovid should be available without a positive Covid test

Type 2 diabetes prevention programs work at large scale: study

Ionis has late

Kaiser Permanente unions announce official strike date

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Listen: Who gets the credit for GLP

hotspot

knowledge

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

FDA reorg will put new emphasis on investigations, sources say

What does generative AI mean for health care? We asked experts

Biogen shutters digital health group, ends Apple study, in cost cutting move

As demand for Covid shots wanes, Moderna seeks its next success

Publishing genetic code of viruses could cause disaster

Cancer drug shortages should be causing more outrage

Medical school prerequisites are outdated

Alkermes shareholders re

Why do women spend more than men on medical expenses?

focus

Sudafed saga points to U.S. issues with evaluating older drugs

White House drug czar issues call for 'recovery

Listen: Who gets the credit for GLP

A letter from the executive editor: STAT UnitedHealth investigation

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Kaiser Permanente unions announce official strike date

knowledge

leisure time

hotspot

Wikipedia